Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1531 AL 1545

[The usefulness of SPECT with 123I-ioflupane (DaTSCAN) in Parkinsonism induced by pharmaceuticals]

Duran-Ferreras E, Duran-Ferreras A.

Rev Neurol. 2011 Mar 16;52(6):382-3.

Resting tremor in Parkinson disease: is the pallidum to blame?

Boecker H, Brooks DJ.

Ann Neurol. 2011 Feb;69(2):229-31. doi: 10.1002/ana.22358.

Upregulation of D2-class signaling in dopamine-denervated striatum is in part mediated by D3 receptors acting on Ca V 2.1 channels via PIP2 depletion

Prieto GA, Perez-Burgos A, Palomero-Rivero M, Galarraga E, Drucker-Colin R, Bargas J.

J Neurophysiol. 2011 May;105(5):2260-74. doi: 10.1152/jn.00516.2010. Epub 2011 Mar 9.

Modified constraint-induced movement therapy improves fine and gross motor performance of the upper limb in Parkinson disease

Lee KS, Lee WH, Hwang S.

Am J Phys Med Rehabil. 2011 May;90(5):380-6. doi: 10.1097/PHM.0b013e31820b15cd.

Creatine in mouse models of neurodegeneration and aging

Klopstock T, Elstner M, Bender A.

Amino Acids. 2011 May;40(5):1297-303. doi: 10.1007/s00726-011-0850-1. Epub 2011 Mar 10.

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease

Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin MC, Destée A, Ferrarese C, Ferraris A, Gibson JM, Gispert S, Hadjigeorgiou GM, Jasinska-Myga B, Klein C, Krüger R, Lambert JC, Lohmann K, van de Loo S, Loriot MA, Lynch T, Mellick GD, Mutez E, Nilsson C, Opala G, Puschmann A, Quattrone A, Sharma M, Silburn PA, Stefanis L, Uitti RJ, Valente EM, Vilariño-Güell C, Wirdefeldt K, Wszolek ZK, Xiromerisiou G, Maraganore DM, Farrer MJ; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

Ann Neurol. 2011 May;69(5):778-92. doi: 10.1002/ana.22321. Epub 2011 Mar 9.

Embryonic stem cell extracts: use in differentiation and reprogramming

Han J, Sidhu K.

Regen Med. 2011 Mar;6(2):215-27. doi: 10.2217/rme.11.8.

Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities

Chiurchiù V, Maccarrone M.

Antioxid Redox Signal. 2011 Nov 1;15(9):2605-41. doi: 10.1089/ars.2010.3547. Epub 2011 Jun 6.

Spinal cord and parkinsonism: neuromorphological evidences in humans and experimental studies

Vivacqua G, Casini A, Vaccaro R, Salvi EP, Pasquali L, Fornai F, Yu S, D'Este L.

J Chem Neuroanat. 2011 Dec;42(4):327-40. doi: 10.1016/j.jchemneu.2011.03.001. Epub 2011 Mar 22.

Neurodegenerative disease and adult neurogenesis

Winner B, Kohl Z, Gage FH.

Eur J Neurosci. 2011 Mar;33(6):1139-51. doi: 10.1111/j.1460-9568.2011.07613.x.

[Functional assessment of nigro-striatal pathway with FP-CIT in patients with multiple system atrophy subtype C]

Martínez del Valle Torres MD, Ramos Moreno E, Amrani Raissouni T, Ortega Lozano SJ, Sanz Viedma S, Jiménez-Hoyuela JM.

Med Clin (Barc). 2011 Oct 15;137(10):440-3. doi: 10.1016/j.medcli.2010.11.020. Epub 2011 Mar 10.

Utilising functional MRI (fMRI) to explore the freezing phenomenon in Parkinson's disease

Shine JM, Ward PB, Naismith SL, Pearson M, Lewis SJ.

J Clin Neurosci. 2011 Jun;18(6):807-10. doi: 10.1016/j.jocn.2011.02.003. Epub 2011 Mar 12.

Adenosine and related drugs in brain diseases: present and future in clinical trials

Lopes LV, Sebastião AM, Ribeiro JA.

Curr Top Med Chem. 2011;11(8):1087-101. doi: 10.2174/156802611795347591.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias